# Lidocaine + Epinephrine

## Lidophrine inj (2%+E) 20mL

| TAH Drug Code      | [**ILID2E**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ILID2E)                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | For production of local anesth by nerve block or infiltration inj.                                                                                                                                                                                                                                                                                                                                                                              |
| Dosing             | Each mL contains 20mg Lidocaine and 0.02mg Epinephrine. Maximum dose of lidocaine when given with epinephrine is 500 mg in a normal healthy adult. Dental local anesthesia is according to the patient's physical condition and inject the minimum dose that can obtain effective local anesthetic effect. Oral infiltration or mandibular block: Initial dose: 1-2 mL. Children < 10 years usually need no more than 10 mL of Lidophrine 2%+E. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Thyrotoxicosis, hypertension, severe heart disease (particularly when tachycardia is present), diabetes; hypovolaemia, shock, heart block; when inflammation or sepsis is present in the region of the proposed inj. Soln containing epinephrine should not be used for local anesth inj in digits & appendages.                                                                                                                                |
| Adverse Effects    | Common: Nervousness, dizziness, blurred vision, tremor, drowsiness, tinnitus, numbness, disorientation, nausea & vomiting. Less common: Convulsions, unconsciousness, respiratory depression or arrest, hypotension, CV collapse & bradycardia which may lead to cardiac arrest.                                                                                                                                                                |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                            |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                    |

## Xylestesin-A (for Dental) 1.7mL

| TAH Drug Code      | [**IXYA**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IXYA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Local anaesthesia (infiltration and nerve-block anaesthesia) in dentistry. Xylestesin-A is indicated in adults, children and adolescents.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Dosing             | Dosage requirements should be determined on an individual basis. For submucosal infiltration and/or nerve block injection. Avoid intravascular injection. Aspirate the syringe after tissue penetration and before injection to minimize chance of direct vascular injection. Children > 15 years and adult: dosages of 1-4 mL are usually effective. Lidocaine maximum dosage: 500mg (7 mg/kg). Epinephrine maximum dosage: 0.25mg (equivalent to 20 mL). Children 20-30 kg: 0.25-1 mL. Children 30-45 kg: 0.5-2 mL. Lidocaine maximum dosage of children: 5 mg/kg.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | - hypersensitivity to the lidocaine, adrenaline, sodium sulphite, Sodium chloride, Hydrochloric acid. - severe, uncontrolled or untreated excitation and conduction disorders of the heart (e.g. grade II and III AV block, pronounced bradycardia) - acutely d                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Adverse Effects    | Infections and infestations: Oral herpes Immune system disorders: anaphylactic reaction, anaphylactic shock, type I hypersensitivity Psychiatric disorders: confusional state Nervous system disorders: dizziness, headache, somnolence, facial palsy, paresis, syncope, dysarthria Eye disorders: accommodation disorder, blindness, diplopia, eye swelling, vision blurred, eyelid ptosis, mydriasis, ophthalmoplegia Cardiac disorders: palpitations Vascular disorders: haematoma, pallor Respiratory, thoracic and mediastinal disorder: bronchospasm, laryngeal oedema, respiratory failure, throat tightness, wheezing, dyspnoea, cough Gastrointestinal disorders: hypoaesthesia oral, toothache, nausea, tongue oedema, vomiting Skin and subcutaneous tissue disorders: haemorrhage subcutaneous, dermatitis bullous, dermatitis contact, hypoaesthesia facial, pruritus, rash, swelling face General disorders and administration site conditions: medicine ineffective, pain, injection site swelling, injection site haematoma Investigations:allergy test positive, heart rate increased, heart rate irregular Injury, poisoning and procedural complications:Uncommon |
| Pregnancy          | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

## Ziacaine 2%(for Dental) 1.8mL

| TAH Drug Code      | [**IZIA**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IZIA)                                                                                                                                                                                                                                         |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Dental infiltration and dental nerve block.                                                                                                                                                                                                                                                                      |
| Dosing             | 4~6 years:usual dose:0.9ml; max.1.8ml 6~14 years:usual dose:1.35ml; max.2.7ml >15 years:usual dose:1.8ml; max.3.6ml                                                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                    |
| Contraindications  | Thyrotoxicosis, hypertension, severe heart disease (particularly when tachycardia is present), diabetes; hypovolaemia, shock, heart block; when inflammation or sepsis is present in the region of the proposed inj. Soln containing epinephrine should not be used for local anesth inj in digits & appendages. |
| Adverse Effects    | Nervousness, dizziness, blurred vision, tremor, drowsiness, tinnitus, numbness, disorientation, nausea & vomiting.                                                                                                                                                                                               |
| Pregnancy          | No Data                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                    |

